Wood's Ark Investment Management bought a series of biotech stocks, as it has done repeatedly in recent sessions.

Stocks finish mixed Monday with the Nasdaq turning positive to snap a four-day losing streak.

Wall Street looks set to extend last week's declines, with tech stocks leading to the downside, ahead of a key reading of December inflation, Jerome Powell testimony and the start of the fourth quarter earnings season.

Boston-based Beam Therapeutics has agreed to a potential $1.35 billion drug development deal with pharma giant Pfizer.

Intellia Therapeutics rises and other gene-editing stocks follow suit.

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.